Skip to main navigation
Skip to search
Skip to main content
Aston Research Explorer Home
Help & FAQ
Home
Research units
Profiles
Research Outputs
Datasets
Student theses
Activities
Press/Media
Prizes
Equipment
Search by expertise, name or affiliation
Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones
Clifford Bailey
*
*
Corresponding author for this work
School of Biosciences
College of Health and Life Sciences
Aston Research Centre for Health in Ageing
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Thiazolidinediones
100%
Metformin
82%
Insulin Resistance
62%
Type 2 Diabetes Mellitus
57%
2,4-thiazolidinedione
21%
Pioglitazone
19%
Hyperglycemia
13%
Renal Agents
12%
Rosiglitazone
9%
Glucose
9%
Blood Vessels
9%
Plasminogen Activator Inhibitor 1
8%
Adiponectin
8%
Nonesterified Fatty Acids
8%
Liver
7%
LDL Lipoproteins
7%
Platelet Aggregation
7%
Hypoglycemia
7%
Weight Gain
7%
C-Reactive Protein
6%
Triglycerides
6%
Pharmacokinetics
5%
Cardiovascular Diseases
5%
Insulin
5%
Lipids
5%
Blood Pressure
4%
Inflammation
4%